In the present study, we have evaluated the induction of ornithine decarboxylase (ODC) activity in rat liver after acute in vivo administration of different hepatocarcinogens, and correlated the ODC activity peaks with the accumulation of the three ODC-related mRNA species in rat liver at different times after the intraperitoneal injection of different hepatocarcinogens. ODC activity peaked 16 h after 2-acetylaminofluorene (2-AAF) treatment, while accumulation of the three ODC-mRNAs, starting 4 h after the injection, was maximal 6 h later. Thioacetamide (TAA) administration caused a single peak of ODC activity 20 h after treatment, while there had been the maximum increases of the three ODC-mRNAs 4-h earlier. The first ODC activity peak occurred 20 h after treatment with 3'-methyl-4-(dimethylamino)azobenzene (MDAB), at the same time that accumulation of the ODC-mRNAs was maximum. There was no increase in ODC-mRNA accumulation at 28 h or 36 h after MDAB treatment, the time at which ODC activity once again peaked. All the ODCrelated transcripts accumulated after MDAB treatment, although to different degrees. The 1.7 kilobase (kb) transcript accumulated the most after 2-AAF treatment. After TAA treatment, the 2.2 kb mRNA was the most abundantly expressed. In neonatal liver, in which ODC activity is physiologically high, the 1.7 kb mRNA is expressed more abundantly than the other two ODC-related transcripts. These results demonstrate that the peak of ODC enzyme activity does not always correspond in time with the peak of ODC-mRNA accumulation,* that different hepatocarcinogens induce different patterns of accumulation of the ODC-related transcripts; and that the minor ODCrelated transcript (1.7 kb) in rat liver seems to be expressed not only constitutively but is also inducible.
Introduction
Ornithine decarboxylase (ODC*; EC 4.1.1.17), which catalyzes the decarboxylation of ornithine to putrescine, is the first and rate-limiting enzyme in the polyamine biosynthetic pathway (1-3). Mammalian ODC is a tightly regulated enzyme, since it is regulated at various levels including transcription, mRNA synthesis, translational efficiency, post-translational modifications and by an ODC-inhibitory protein, called ODC-antizyme (1-3).
It is widely accepted that this tight, multilevel regulation of ODC is one of the cellular mechanisms that enable the ODC activity of mammalian cells to respond rapidly to different stimuli affecting cell growth and differentiation (2, 4, 5) . Indeed, although ODC activity level is generally low in both resting and slowly growing cells, it is rapidly induced in response to a large number of stimuli, both mitogenic and not, such as hormones (4) , growth factors (2, 5) , tumor promoters, chemical carcinogens, oncogenic viruses and oncogene activation (6, 7) . It has been firmly established that ODC plays a pivotal role in the processes of growth (whether restrained or unrestrained) and differentiation of mammalian cells (2, (4) (5) (6) . This concept has been reinforced by recent studies, which have demonstrated that: (i) c-myc; a well known proto-oncogene greatly influencing mammalian cell growth (8) , induces both the expression of the ODC gene and ODC activity (9) (10) (11) (12) (13) ; (ii) c-fos, another proto-oncogene also implicated in the control of cell proliferation and differentiation (8) , is a positive regulator of ODC transcription (14) .
However, the exact role of ODC in neoplastic transformation has not yet been deciphered and it remains controversial. Importantly, several lines of experimental evidence have indicated that abnormalities in ODC activity levels and/or, even more so, derangements of ODC regulatory mechanisms, both eventually leading to intracellular polyamine accumulation, are invariably, and therefore constitutively, associated with both the neoplastic transformation of mammalian cells and the growth of mammalian tumors (6, 15) . Recently, alterations of ODC gene expression in preneoplastic nodules and in carcinomas of rat liver have been described (16) . In addition, recent in vitro studies suggest that ODC overexpression may confer oncogenic properties to immortalized cell lines (17) (18) (19) . However, recent evidence has been provided that: (i) the incidence of skin tumors elicited in the epidermis of transgenic mice overexpressing the human ODC gene by the initiation-promotion protocol is only greatly enhanced (20) ; (ii) the ODC overexpression by itself is not sufficient for the malignant transformation of murine skin cells and it can only contribute to tumor development in initiated premalignant epidermal cells (21) ; (iii) the induction of c-fos, c-myc and ODC-mRNAs is not directly correlated with susceptibility to tumor promotion in the skin of two strains of mice by phorbol esters (22) .
Because the ODC gene is an 'early response gene' (23, 24) , clarification of the molecular basis for ODC induction by carcinogens might provide valuable information about the early molecular events that regulate neoplastic transformation of mammalian cells or, at least, about the early events following the interaction between a carcinogen and its target cells (6, 23) . The present study was undertaken to explore the effects on the ODC gene expression in rat liver after a single in vivo treatment with a hepatocarcinogen. We investigated in parallel the changes in both hepatic ODC activity level and the hepatic content and pattern of ODC-related mRNA species elicited by the hepatocarcinogen. The hepatocarcinogens we used were 2-acetylaminofluorene (2-AAF), thioacetamide (TAA) and 3'-methyl-4-(dimethylamino)azobenzene (MDAB), each of which was given at a dose large enough to induce hepatic ODC activity, but to cause neither development of hepatoma nor a severe degree of injury to hepatic tissue. There was another reason for doing this research in parallel. This was that the induction of ODC activity by different physiological growth stimuli or by tumor promoters were frequently connected with increased levels of ODC-related mRNA species (2, 4, 5, 25) , although in many systems the ODC-related mRNA species were much less increased than ODC activity, and in a few cases there was no increase at all (26) (27) (28) (29) (30) (31) (32) . 
Materials and methods

Chemicals
Animals and treatments
Adult male Sprague-Dawley rats (Charles River, Chalco, Italy), weighing 200-220 g, were used. The rats were maintained on light-dark cycle and fed-fasted cycle of 12:12 h daily. At the beginning of the treatment, adult rats were randomly distributed into different treatment groups. 2-AAF and MDAB were dissolved in peanut oil, and TAA was dissolved in neutralized saline. Each of these hepatocarcinogens was administered intraperitoneally (i.p.) in a single injection. To minimize the diurnal changes in ODC activity occurring physiologically in adult rat liver (33) , most of the treatments with the different hepatocarcinogens were given at appropriate times, so that rats could be killed between 10:00 a.m. and noon. The routinary dose was: 15 mg/100 g body weight (b.w.) for 2-AAF; 10 mg/100 g.b.w. for TAA; 5 mg/ 100 b.w. for MDAB. The controls for each hepatocarcinogen-treated group were given the same volume of the solvent. The intervals after treatment at which control and hepatocarcinogen-treated adult rats were killed by cervical dislocation are reported in Figure 1 , panels A and B and Figure 2 . The livers were homogenized in 2 volumes (v/w) of iced medium, whose composition has been previously described (33) . A fragment of each liver was frozen immediately in liquid nitrogen and stored at -70°C for ODC gene expression analysis. For TAA-treated rats, another sample of their livers was used for histologic examination (see later). The newborn male rats used in this study were 5-days-old and were suckling until killed. Each experiment followed the international criteria for the use and care of experimental animals in research.
ODC enzimatic activity assay ODC activity was determined by the release of I4 CO2 from [
14 C]-L-ornithine in the 20 000 g supernatant, as previously described (33) . The total protein in the reaction was measured as previously described (33) , using bovine serum albumin as standard.
Expression of ODC mRNAs
Total RNA was extracted from livers of rats of each experimental group at each time point, using the single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform (34) . RNA was quantified spectrophotometrically (Uvikon 860, Kontron Instruments). The ratio A 2 6o
:A 28O was greater than 1.8. Samples were loaded on 1.5% agarose gel containing 2.2 M formaldehyde and fractionated by electrophoresis. A 0.9 kilobase (kb) double-stranded Hind Ill/Hind III restriction fragment of mouse kidney ODC-cDNA from pODC16 (35) [kindly provided by Dr O.A.Janne, University of Helsinki (Finland)] was gel purified. The fragment contains 685 base pairs (bp) of the ODC coding sequence and 287 bp of the 3' untranslated region (UTR), 23 nucleotides prior to the first polyadenylation signal. The probe was radiolabeled by nick translation according to the manufacturer's instructions. The Northern blots were prehybridized at 42°C for 4 h and hybridized with the heat-denaturated radiolabeled probe for 24 h at the same temperature. After washes, filters were autoradiographed with Kodak X-Omat-AR-X ray films in an intensifier Kodak X-Omatic screen, at -70°C, for an appropriate time period. The amounts of the hybridized 1.7, 2.2 and 2.6 kb ODC-mRNAs from livers of control and treated rats were quantified by scanning the autoradiographs produced by Northern blot analysis with a laser densitometer (Model 300A Computing Densitometer, Molecular Dynamics, Sunnyvale, CA, USA).
Assays of the activities of several enzymes in serum or plasma
Among the different enzymatic tests employed in the assessment of hepatocellular damage, we had chosen the aspartate and alanine aminotransferases [serum glutamic oxaloacetic transaminase (AST; SGOT) (EC 2.6.1.1) and serum glutamic pyruvic transaminase (ALT; SGPT) (EC 2.6.1.2)] and plasma sorbitol dehydrogenase (SDH) (EC 1.1.1.14) . All these enzymes are widely considered to be the most sensitive indicators of liver cell injury (36) . ASTand ALT-activity were measured as reported by Chanda et al. (37) , SDH activity as reported by Calamari et al. (38) .
Histopathologic examination
For histologic estimates of cell damage caused by TAA, liver lobes from 3-4 TAA-treated rats, killed at the time when induction of ODC activity had peaked or nearly so (16 and 20 h after injection), were fixed in 10% formalin and then embedded in paraffin. The sections (8 p.m thick) were stained with hematoxylin and eosin for histopathologic examination under a light microscope. The sections were examined thoroughly for evidence of the centrilobular injury, since it is well known that TAA affects mainly hepatocytes of the perivenous region (39, 40) .
Statistical analyses
Each entire set of data for enzymatic ODC activity obtained for each hepatocarcinogen was first examined by two-way analysis of variance (ANOVA), as described by Armitage and Berry (41) . The homogeneity of variance of the groups of data depicting each ODC kinetics was determined by the test of Bartlett (42) . The results of this test always gave x 2 values, which showed that the variances did not significantly differ. ANOVA demonstrated a significant difference between treatments (P < 0.01) as well as between times (P < 0.01). Duncan's multiple range test (43) was used to evaluate which of the observed levels in each ODC kinetics was significantly different from others. The statistical significance of the differences between each pair of means for each experimental time for each ODC enzymatic kinetics was evaluated by Student's (-test. In each statistical test, an a level of 0.05 or less was always fixed as the limit of statistical significance.
Results
Inducibility of hepatic ODC enzyme activity and its kinetics
Before we tested the capacity of the hepatocarcinogens we had chosen to induce ODC activity, we studied the effects of their solvents on the basal levels of ODC activity. We found that basal ODC activity was not significantly modified by the solvents, even at long periods after the injection (results not shown). All the hepatocarcinogens injected in vivo induced ODC enzyme activity within different time-courses and different peak-levels in relation to the different hepatocarcinogens (Figures 1 and 2) . The increase of the dose of each carcinogen to near double that reported in Materials and methods, did not significantly change the kinetics of hepatic ODC activity (results not shown). The hepatic ODC responses to 2-AAF and TAA were both monophasic ( Figure 1A and B) . The peak of ODC induction by 2-AAF was observed 16 h after administration of the drug ( Figure 1A) , whereas the peak of ODC induction by TAA occurred 4 h later ( Figure IB) . ODC activity in livers from TAA-treated rats declined more slowly than in livers from 2-AAF-treated rats ( Figure 1A and B) . The kinetics of the ODC enzyme activity after TAA agree well with those previously reported by Fausto (44), Kameji et al. (45) and ourselves (46) . On the contrary, the kinetics of the ODC enzyme activity after 2-AAF treatment were slightly different from those previously reported by other investigators (47) . However, it should be remembered that the sensitivity to 2-AAF varies considerably in the different strains of rat (48) . The time course of ODC activity induced by MDAB was biphasic, with a first and transient peak increase 20 h after treatment and a second peak, also transient, 16 h later ( Figure  2 ). The ODC peak-level induced by TAA was the highest (Figures 1 and 2) .
Time-courses of accumulation of the hepatic ODC-related mRNAs
As for the inducibility of ODC enzyme activity, injections of the solvents alone did not modify to any significant extent the pattern of the normal expression of the ODC-related mRNA species (Northern blot analysis not shown). After increasing the dose of each carcinogen to nearly double that reported in Materials and methods, we did not observe any significant modifications of the pattern of accumulation of the ODCrelated transcripts (Northern blot analysis not shown). Adult rat liver contains three different ODC-transcripts, two major ones, of 2.6 and 2.2 kb in size and a smaller one of 1.7 kb ( Figure 3A , B and C). These results are in agreement with those of other authors (49, 50) who have demonstrated that the smallest ODC transcript is present in rat tisues only and that it is expressed constitutively. However, it has been suggested that the 1.7 kb transcript might be due to cross-hybridization to a different gene product or to 18S ribosomal RNA (51, 52) . However, comparison of the variations in the accumulation of the three ODC mRNAs and the ethidium bromide staining of each gel, which demonstrated that equal amounts of the 18S ribosomal subunit were present after different treatments, lead us to reasonably exclude cross-hybridization of the ODC probe we used with the 18S ribosomal subunit (see Figure 3 , right side). In addition, after increasing the stringency conditions of washing membranes the 1.7 kb transcript was still detectable (Northern blot analysis not shown). Four hours after 2-AAF administration, the ODC-mRNAs (especially the smallest species of 1.7 kb) had accumulated significantly ( Figure 3A ), but the increase in the level of ODC enzyme activity was significant 6 h later ( Figure 1A) . The results of densitometric analysis of the Northern blots ( Figure 4) shows that 4 h after 2-AAF treatment the amount of 1.7 kb transcript had increased 5-fold, while the 2.2 kb transcript had increased 3-fold 6 h later, with a concomitant increase of the 2.6 kb species of the same order of magnitude. Thereafter, the accumulation of the ODC-mRNAs began to decline ( Figure 3A) . The peak accumulation of the ODC-related mRNAs induced by TAA administration occurred 16 h after treatment ( Figure 3B ), preceding the peak of the ODC enzyme activity by 4 h ( Figure  IB) . The levels of the ODC-related mRNAs were still high 20 h after TAA injection ( Figure 3B ). The results of densitometric analysis of the Northern blots (Figure 4) show that the amount of the 2.2 kb mRNA increased 13-fold 16 h after TAA treatment and 8-fold by 4 h later. Therefore, the pattern of accumulation of the ODC-transcripts in livers from TAAtreated rats differs from those observed after the other hepatocarcinogens ( Figure 3 ). There was maximal accumulation of the ODC-transcripts 20 h after MDAB administration ( Figure  3C ) and it was concomitant with the first peak of ODC enzyme activity (Figure 2 ), although there already had been an increase in the ODC-transcripts 4 h earlier ( Figure 3C ). The results of densitometric analysis of the Northern blots ( Figure 4) show that after MDAB treatment the amounts of the 2.2 kb and the 2.6 kb transcripts had increased four times over those in the controls, whereas the amounts of the 1.7 kb transcript had doubled. Interestingly enough, the second peak of the ODC enzyme activity after MDAB treatment ( Figure 2 ) was neither preceded by nor coincident with any accumulation of the ODC-mRNAs ( Figure 3C ). Finally, it is widely known that the typical feature of the ontogeny of the ODC enzyme activity in mammalian organs is the high level of activity during fetal development and during neonatal life (53, 54) . Thereafter, the activity levels decline progressively (53, 54) , and this has also been demonstrated in rat liver (53) . Therefore, we determined the levels of ODC enzyme activity and the pattern of the ODC-related mRNA species in parallel in livers of newborn rats, since we considered this organ at this time of its development to be a natural model, in which the ODC enzyme activity is induced physiologically. As expected, the level of the ODC enzyme activity was extremely high (mean value 219.9 ± 16.47 pmol CO 2 /mg prot/30 min, for eight newborn rats), which is significantly higher (P < 0.01) than that in normal adult liver (Figures 1 and 2) . A typical pattern of accumulation of the ODC-related mRNAs of newborn rat liver is presented in Figure 5 , which shows a marked and quantitatively predominant accumulation of the 1.7 kb ODC-related transcripts. This result is different from that previously reported by Blackshear et al. (51) , who found that only the ODC-mRNA of 2.2 kb is expressed predominantly in newborn rat liver.
Enzyme levels
Serum activity levels of ALT and AST and plasmatic activity level of SDH were measured as markers of hepatotoxicity after the different treatments with hepatocarcinogens at those times of each ODC kinetics when induction of enzyme activity had peaked or nearly so. Data reported in Table I show that ALT-and AST-levels were significantly increased at 16 and 20 h after TAA treatment, whereas a SDH elevation was observed only at 20 h after. Treatment with 2-AAF resulted in the levels of both the aminotransferases being significantly decreased only at 20 h, without significant changes in SDH activity levels at any tested time (see Table I ). The treatment with MDAB caused significant increases in AST-and ALTactivity at 20 and 16 h, respectively (see Table I ), and SDH activity levels were significantly increased at 20 and 36 h (see Table I ).
Histopathologic examination of livers from TAA-treated rats
Since it was evident from data reported in Table I that TAA was the most hepatotoxic agent used, we performed a histopathologic examination of only those livers from TAAtreated rats, to exclude the possibility that the ODC induction we observed might have been due to some regenerative phenomena in the liver. The liver sections were examined for necrotic cells and extent of inflammation. The absence of any significant degree of necrosis and inflammation, at least under The enzyme values for serum or plasma from rats injected with peanut oil (controls for 2-AAF or MDAB-treated rats) were the same (not shown) as for serum or plasma from saline-injected rats. The dose of 2-AAF, TAA and MDAB and experimental details are given in Materials and methods. Values are means ± SEM for three to six animals for each experimental point. Results significantly different from the control group are indicated: *P < 0.05 Dunnett's test (69) . a light microscope confirmed that the dose we used was not a necrogenic one, which was in agreement with our previous result (46) .
Discussion
The results of this study indicate that in vivo administration of different hepatocarcinogens induces different kinetics of ODC enzyme activity along with different patterns of accumulation of the different species of the ODC-related mRNAs in the rat liver. We have demonstrated that the maximum accumulation of the different species of ODC-related mRNAs is concomitant with the first peak of ODC activity after the in vivo MDAB treatment. On the contrary, the maximal accumulation of the ODC-related transcripts occurs before the peaks of ODC activity after in vivo treatment with 2-AAF or TAA. Therefore, for these two, it is reasonable to suppose that the increases in enzyme activity are due, at least in part, to increases in ODC-related mRNAs. Instead, the ODC-related mRNA levels did not change in correspondence with the second peak of ODC enzyme activity after in vivo MDAB treatment. There are more experimental data for different biological systems, either in vitro or in vivo, in which elevated levels of ODC activity are concomitant with elevated levels of ODC-related mRNAs (recently reviewed in 2,4,5) than for those in which there is a discrepancy between the induction of ODC activity and change in the amounts of the ODCrelated mRNAs (26) (27) (28) (29) (30) (31) (32) . Interestingly, when ODC activity levels are decreased by different types of negative effectors, it has also been demonstrated that there may be concomitant decreases in ODC-related mRNAs (55-58) or may not be (59, 60) .
Our studies have shown that the patterns of accumulation of the three ODC-related mRNA species in rat liver after in vivo treatment are different after different hepatocarcinogens. This means that each of the hepatocarcinogens we used is preferentially inducing quantitatively one or two species of the three ODC-related transcripts. In fact, the ODC-related transcript that accumulated most abundantly after 2-AAF treatment is 1.7 kb. In this respect, our results slightly disagree with those reported by van Kranen et al. (61) , who found that livers of rats (Wistar strain) treated with 2-AAF showed increased levels of the 2.2 kb and 2.6 kb ODC mRNA species. After TAA treatment, the 2.2 kb mRNA was the most abundantly expressed, resembling the pattern of accumulation of the ODC-mRNAs in rat liver after partial hepatectomy (50) . We have demonstrated that the accumulation of the ODC transcripts after MDAB treatment involved the three ODC-mRNAs, although to different degrees.
Our results demonstrating that the 1.7 kb transcript is expressed constitutively in rat liver are in agreement with those reported by Hirvonen et al. We have also observed high levels of ODC enzyme activity concomitant with an accumulation of the ODC-related mRNAs in neonatal rat livers, in which the 1.7 kb transcript is expressed the most. Our results suggest that there is a decrease in the expression of the 1.7 kb transcript in rat liver throughout the lifespan, at least from neonatal to adult ages.
From measuring the levels of some enzymes in serum or plasma of hepatocarcinogen-treated rats, we demonstrated that a small degree of hepatic injury occurred after the different treatments, at least during the short times we tested, namely at those times when induction of ODC activity had peaked or nearly so. This is further supported by the absence of any histologically evident necrosis even in the case of livers from rats treated with TAA, which was the most hepatotoxicant agent we used, at least from the point of view of the changes in the activity levels of the enzyme markers of hepatotoxicity (see Table I ). It is exceedingly difficult, however, to assess how much of the ODC induction is specifically connected to the 'initiation' process, if any, by the injected hepatocarcinogen and how much is connected to the reparative processes, which definitely occur in the hepatocytes after the hepatocarcinogeninduced injury. In fact, it must here be remembered that: (i) most of the chemical hepatocarcinogens are able to 'initiate' liver cancer development because they induce liver cell death (necrosis) (48, (62) (63) (64) (65) , (ii) proliferation of hepatocytes certainly participates in the early events in the carcinogenic process by hepatocarcinogens, although its exact role still remains unknown (48, (62) (63) (64) (65) . It is widely accepted, however, that induction of ODC activity and ODC gene activation in target tissue after carcinogen exposure, observed by us and other authors (reviewed in 6, 15) , and whatever the different mechanisms are involved in causing them, have to be considered as one of the early metabolic consequences strictly connected to the interaction between a carcinogen and its target tissue or organ (6, 15) . If necrosis alone and/or liver cell repair alone were to determine ODC induction and ODC gene activation after acute hepatocarcinogen treatment with all of the compounds tested, there would be similar patterns of expression of ODC-mRNAs.
In conclusion, it is tempting to speculate that the induction of hepatic ODC activity by hepatocarcinogens we observed, may occur through preferential accumulation of some of the three hybridizable ODC-related mRNAs. We also cannot exclude that the cellular heterogeneity of the rat liver (66, 67) as well as a possible but not yet demonstrated zonation of ODC gene response to hepatocarcinogens in rat liver (68) , could play roles in determining the different patterns of accumulation of ODC-related transcripts observed in livers from hepatocarcinogen-treated rats.
